Madira, Bebith L.
HRN: 26 63 31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2025
CEFTRIAXONE 1G (VIAL)
02/02/2025
02/09/2025
IVT
2g
OD
PTB Presumptive, CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes